Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Jauhiainen

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Biomarkers in Medicine|April 30, 2016
COPD biomarkers as tools for decision making in early clinical drug developmentZiad Taib, Alexandra Jauhiainen
Entropy (Basel, Switzerland)|May 28, 2022
Focused Information Criterion for Restricted Mean Survival Times: Non-Parametric or Parametric EstimatorsSzilárd Nemes, Andreas Gustavsson, Alexandra Jauhiainen
Plos One|March 4, 2014
Inferring regulatory networks by combining perturbation screens and steady state gene expression profilesAli Shojaie, Alexandra Jauhiainen, Michael Kallitsis, et al.
Biostatistics (Oxford, England)|June 16, 2012
Transcriptional and metabolic data integration and modeling for identification of active pathwaysAlexandra Jauhiainen, Olle Nerman, George Michailidis, et al.
Plos One|October 26, 2017
Exploration of human brain tumour metabolism using pairwise metabolite-metabolite correlation analysis (MMCA) of HR-MAS 1H NMR spectraBasetti Madhu, Alexandra Jauhiainen, Sean McGuire, et al.
RNA (New York, N.Y.)|February 19, 2009
mRNA stability changes precede changes in steady-state mRNA amounts during hyperosmotic stressClaes Molin, Alexandra Jauhiainen, Jonas Warringer, et al.
Contemporary Clinical Trials Communications|June 17, 2021
Complexity of design in early phase respiratory clinical trials; evaluating impact of primary endpoints and sponsor sizeNicolas Marco-Ariño, Alexandra Jauhiainen, Joanne Betts, et al.
Statistics in Medicine|March 13, 2026
Location-Scale Latent Process Model for Repeated Ordinal Patient-Reported OutcomesAgnieszka Król, Robert Palmér, Jacob Leander, et al.
Environmental Science & Technology|August 30, 2008
Evolutionary conservation of human drug targets in organisms used for environmental risk assessmentsLina Gunnarsson, Alexandra Jauhiainen, Erik Kristiansson, et al.
Bioinformatics (Oxford, England)|April 9, 2014
Normalization of metabolomics data with applications to correlation mapsAlexandra Jauhiainen, Basetti Madhu, Masako Narita, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Biomarkers in Medicine|April 30, 2016
COPD biomarkers as tools for decision making in early clinical drug developmentZiad Taib, Alexandra Jauhiainen
Entropy (Basel, Switzerland)|May 28, 2022
Focused Information Criterion for Restricted Mean Survival Times: Non-Parametric or Parametric EstimatorsSzilárd Nemes, Andreas Gustavsson, Alexandra Jauhiainen
Plos One|March 4, 2014
Inferring regulatory networks by combining perturbation screens and steady state gene expression profilesAli Shojaie, Alexandra Jauhiainen, Michael Kallitsis, et al.
Biostatistics (Oxford, England)|June 16, 2012
Transcriptional and metabolic data integration and modeling for identification of active pathwaysAlexandra Jauhiainen, Olle Nerman, George Michailidis, et al.
Plos One|October 26, 2017
Exploration of human brain tumour metabolism using pairwise metabolite-metabolite correlation analysis (MMCA) of HR-MAS 1H NMR spectraBasetti Madhu, Alexandra Jauhiainen, Sean McGuire, et al.
RNA (New York, N.Y.)|February 19, 2009
mRNA stability changes precede changes in steady-state mRNA amounts during hyperosmotic stressClaes Molin, Alexandra Jauhiainen, Jonas Warringer, et al.
Contemporary Clinical Trials Communications|June 17, 2021
Complexity of design in early phase respiratory clinical trials; evaluating impact of primary endpoints and sponsor sizeNicolas Marco-Ariño, Alexandra Jauhiainen, Joanne Betts, et al.
Statistics in Medicine|March 13, 2026
Location-Scale Latent Process Model for Repeated Ordinal Patient-Reported OutcomesAgnieszka Król, Robert Palmér, Jacob Leander, et al.
Environmental Science & Technology|August 30, 2008
Evolutionary conservation of human drug targets in organisms used for environmental risk assessmentsLina Gunnarsson, Alexandra Jauhiainen, Erik Kristiansson, et al.
Bioinformatics (Oxford, England)|April 9, 2014
Normalization of metabolomics data with applications to correlation mapsAlexandra Jauhiainen, Basetti Madhu, Masako Narita, et al.
Pageof 3